EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Leuprorelin Suppresses Angiogenesis and Malignant Progression in Endometrial Cancer via Downregulation of the ELAVL1/VEGFA Axis

NingNing Zhang iD, Fang Zhao, LiMei Tan

Journal of Biochemical and Molecular Toxicology · 2026-11 · 40 (11)

DOI: 10.1002/jbt.71163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 01.11.2026. Verfasst von NingNing Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology, Shijiazhuang People's Hospital, Shijiazhuang City, Hebei Province, China. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Neovascularization, Pathologic, Vascular Endothelial Growth Factor A, Down-Regulation. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leuprorelin, a gonadotropin‐releasing hormone (GnRH) agonist, is currently used clinically to suppress estrogen‐dependent endometrial cancer (EC) through pituitary desensitization. However, whether this agent exerts direct anti‐neoplastic effects via post‐transcriptional regulatory mechanisms remains unclear. The phenotypic effects of leuprorelin were evaluated in EC cell lines using colony formation, 5‐ethynyl−2’‐deoxyuridine (EdU) incorporation, Transwell migration, wound healing, flow cytometry, and HUVEC tube formation assays. Mechanistic exploration employed RNA immunoprecipitation (RIP), mRNA decay kinetics analysis, and RNA fluorescence in situ hybridization combined with immunofluorescence microscopy. A murine xenograft model system was implemented for in vivo validation studies. Leuprorelin treatment significantly reduced proliferation and migration of EC cells, induced apoptosis, and suppressed HUVEC tube formation. At the molecular level, leuprorelin administration reduced cytoplasmic accumulation of ELAVL1, an RNA‐binding protein that physiologically associates with VEGFA transcripts and enhances their stability. This reduction resulted in accelerated decay of VEGFA mRNA and subsequent downregulation of VEGFA protein expression. Forced overexpression of VEGFA substantially abrogated the anti‐tumor effects mediated by leuprorelin. In nude mouse xenograft models, leuprorelin administration suppressed tumor growth and tumor‐associated neovascularization, effects that were reversed upon VEGFA overexpression. Leuprorelin impedes EC progression by disrupting ELAVL1‐mediated stabilization of VEGFA mRNA, highlighting the ELAVL1/VEGFA axis as a potential therapeutic target for anti‐angiogenic therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsNeovascularization, PathologicVascular Endothelial Growth Factor ADown-RegulationELAV-Like Protein 1LeuprolideNeoplasm ProteinsFemaleHumansAnimalsMice, NudeMiceCell Line, TumorGene Expression Regulation, NeoplasticDisease ProgressionXenograft Model Antitumor AssaysSignal Transduction

Stichwörter der Autor:innen

ELAVL1VEGFAangiogenesisendometrial cancerleuprorelin

Substanzen

Vascular Endothelial Growth Factor AELAV-Like Protein 1LeuprolideELAVL1 protein, humanNeoplasm Proteins

Autor:innen und Institutionen

  • Department of Gynaecology, Shijiazhuang People's Hospital, Shijiazhuang City, Hebei Province, China.
  • Department of Rehabilitation, Shijiazhuang People's Hospital, Shijiazhuang City, Hebei Province, China.

ORCID-Profile: NingNing Zhang

Zitieren

APA

Zhang, N., Zhao, F., & Tan, L. (2026). Leuprorelin Suppresses Angiogenesis and Malignant Progression in Endometrial Cancer via Downregulation of the ELAVL1/VEGFA Axis. Journal of Biochemical and Molecular Toxicology, 40(11). https://doi.org/10.1002/jbt.71163

Vancouver

Zhang N, Zhao F, Tan L. Leuprorelin Suppresses Angiogenesis and Malignant Progression in Endometrial Cancer via Downregulation of the ELAVL1/VEGFA Axis. Journal of Biochemical and Molecular Toxicology. 2026;40(11). doi:10.1002/jbt.71163

BibTeX
@article{Zhang2026,
  author = {Zhang, NingNing and Zhao, Fang and Tan, LiMei},
  title = {Leuprorelin Suppresses Angiogenesis and Malignant Progression in Endometrial Cancer via Downregulation of the ELAVL1/VEGFA Axis},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  volume = {40},
  number = {11},
  doi = {10.1002/jbt.71163}
}
Kostenlos starten →